Translating advances from the basic biology of aging into clinical application

Area of Science:

• Gerontology
• Translational Medicine
• Biomedical Research

Background:

• Interventions show promise for extending lifespan and healthspan in animal models.
• Translating these findings to human clinical applications requires significant advancement beyond typical drug development.
• Key challenges include designing appropriate preclinical and clinical trial paradigms.

Purpose of the Study:

• To outline the necessary steps for translating aging interventions from experimental animals to human clinical applications.
• To identify critical considerations for developing effective clinical trials targeting aging processes.
• To address roadblocks in research funding and expertise for aging research.

Main Methods:

• Reviewing current strategies for advancing aging research into clinical practice.
• Identifying essential components for realistic preclinical and clinical trial designs.
• Discussing the need for biomarkers and outcome measures acceptable to regulatory agencies.

Main Results:

• Clinical translation requires focusing on subjects with age-related diseases or frailty.
• Emphasis should be placed on short-term, clinically relevant outcomes rather than long-term lifespan or healthspan.
• Development of regulatory-accepted biomarkers and outcome measures is essential.

Conclusions:

• Bridging the gap from basic aging research to clinical application necessitates a multidisciplinary approach.
• Overcoming funding limitations and fostering expertise in aging biology, geriatrics, and clinical trial conduct are critical.
• Strategic planning for clinical trials targeting fundamental aging processes is paramount for future success.